Stallion India Fluorochemicals is set for a strong debut with its IPO listing on January 23, 2025. With overwhelming subscription and a positive grey market premium, the company anticipates a 45.56% premium over its issue price of ₹90. The IPO raised ₹199.45 crore, signaling strong investor confidence in its growth prospects.
India-based Stallion India Fluorochemicals, a company known for its specialization in the production and distribution of fluorochemicals used in various industrial sectors, is gearing up for its initial public offering (IPO) listing on January 23, 2025. The company has successfully raised ₹199.45 crore through its IPO, which includes a mix of a fresh issue and an offer for sale of equity shares. The IPO, which opened for subscription from January 16 to January 20, 2025, attracted significant demand across all investor categories, including retail, institutional, and qualified institutional buyers (QIBs).
The IPO shares are set to be listed on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) on the expected listing date. As market participants eagerly anticipate the stock’s performance, one of the key indicators being closely watched is the grey market premium (GMP). The GMP, which provides an early indication of the stock’s potential listing price, currently stands at ₹41 per share. This signals a 45.56% premium over the issue price of ₹90 per share, suggesting a strong debut in the Indian stock market.
The Stallion India Fluorochemicals IPO attracted overwhelming interest, with the issue being subscribed 188.38 times. The retail portion was subscribed 96.90 times, the non-institutional investors (NII) portion was subscribed 422.42 times, and the qualified institutional buyers (QIB) portion was booked 172.93 times. The strong demand reflects confidence in the company’s growth potential within the fluorochemical industry, which is witnessing increasing demand from various sectors, including automotive, electronics, and chemicals.
The company offered 1.79 crore fresh equity shares worth ₹160.73 crore and an offer for sale of 43.02 lakh equity shares aggregating to ₹38.72 crore. The price band for the IPO was set at ₹85 to ₹90 per share, with the listing price now expected to be significantly higher, in line with the current GMP trends.
Sarthi Capital Advisors serves as the book-running lead manager for the Stallion India IPO, while Bigshare Services Pvt Ltd is the registrar handling the issue.
Investors are now eagerly awaiting the January 23 listing, as the positive GMP signals that Stallion India Fluorochemicals may have a strong debut in the Indian stock market, following an oversubscribed IPO.
